CANNABIS STANDARD INDEX BRINGS MUCH-NEEDED CLARITY TO MEDICAL CANNABIS

TORONTO, September 3, 2020 – Reformulary Group is pleased to announce the launch of its Cannabis Standard™ Index. The Index uniformly categorizes medical cannabis products based on objective data, allowing Canadians and the medical community to find accurate, detailed information and to reliably search and compare products. MORE>>